Navigation Links
Vion Reports 2008 Third Quarter and Nine-Month Results
Date:11/3/2008

vo poor-risk acute myelogenous leukemia. Clinical trials of laromustine (Cloretazine(R), VNP40101M) with cytarabine in elderly patients with acute myelogenous leukemia, with temozolomide in brain tumors, and with stem cell transplantation in advanced hematologic malignancies, are also being conducted. Triapine(R), a potent inhibitor of a key step in DNA synthesis, is being evaluated in clinical trials sponsored by the National Cancer Institute. For additional information on Vion and its product development programs, visit the Company's Internet web site at http://www.vionpharm.com.

This news release contains forward-looking statements. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to file a New Drug Application or obtain regulatory approval for its products, particularly laromustine (Cloretazine,VNP40101M), delays in the regulatory approval process or delays or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies, clinical trials or interim clinical trial data are not predictive of safety and efficacy results in later or final clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2007 and Form 10-Q for the quarter ended June 30, 2008. In particular, there can be no assurance
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. AMICAS Reports Financial Results for the Third Quarter Ended September 30, 2008
2. Neovasc Reports Development Progress, Streamlined Operations and Issuance of Options
3. NxStage Reports Third Quarter 2008 Financial Results
4. Study reports Double Balloon Endoscopy useful for diagnosis and treatment of obscure GI bleeding
5. The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
6. Gen-Probe Reports Strong Financial Results for Third Quarter 2008, Raises Full-Year EPS Guidance
7. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
8. Nuvelo Reports Third Quarter 2008 Financial Results
9. Claimsnet.com Reports Third Quarter 2008 Results
10. Remuda Ranch Reports Many Individuals With Eating Disorders Are Not Getting Help They Need
11. Palomar Medical Reports Financial Results for Third Quarter 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 02, 2014 PAINWeek, the National ... the American Pain Society (APS) will return to the ... expertise in pain management to the agenda. This activity ... no fee to attend this program. , On Thursday, ... activity that complies with the FDA’s Risk Evaluation and ...
(Date:9/1/2014)... State University study of deadly force were more likely ... when it came time to shoot, participants were biased ... the trigger against them than against armed white or ... Journal of Experimental Criminology , grow out of dozens ... ethnic and racial minorities shot by police. The studies ...
(Date:9/1/2014)... iFitDress.com, a professional company of women’s dresses and ... modest evening dresses . In addition, the company ... evening gowns. All customers can enjoy a big discount, ... , iFitDress.com is one of the leading suppliers in ... are striving to create more trendy items. The company's ...
(Date:9/1/2014)... AZ (PRWEB) September 01, 2014 Building ... conference, the American Sleep and Breathing Academy ... conference: A Conference for Healthcare Professionals. The event will ... Arizona on April 10th and 11th. This years’ event ... delivered by the ASBA. , In recent years, ...
(Date:9/1/2014)... was associated with mental health and substance use ... protect teens from the consequences of cyberbullying and ... Author: Frank J. Elgar, Ph.D., of McGill University, ... in 5 adolescents has experienced recent online bullying ... risk of mental health problems in teens as ...
Breaking Medicine News(10 mins):Health News:American Pain Society Returns with REMS Training at PAINWeek 2014 in Las Vegas 2Health News:WSU 'deadly force' lab finds racial disparities in shootings 2Health News:WSU 'deadly force' lab finds racial disparities in shootings 3Health News:iFitDress.com: New Modest Evening Wear Selection Now Unveiled Online 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3
... Twelve senior U.S. editors and producers traveled to ... of Africa,s most fascinating countries. A highlight of the ... development, food security, and HIV/AIDS with Ugandan President Yoweri ... at noon , three of the Gatekeepers will discuss ...
... number of childhood deaths across the country have been linked ... this serious and sometimes deadly disease with an annual flu ... a relatively high level across the country, now is the ... do so. It takes about two weeks for the body ...
... Sleep Awareness Week -- March 1-8 -- ... importance of a good night,s sleep by raising ... sleep bruxism. (Logo: http://www.newscom.com/cgi-bin/prnh/20070809/AQTH133LOGO )Sleep bruxism is ... associated with sleep deprivation, stress or misalignment of ...
... showing at the 2009,South Beach Food and Wine Festival, ... 300 stores in South Florida since the brand launched ... include: CVS on Lincoln Road,Miami Beach; Walgreens, Miami Beach; ... Thumb, Penn Dutch, Quick Stop, Shell Gas Stations, and,Chevron. ...
... in Health Incentive ProgramsLYNDHURST, N.J., Feb. 24 ... to the health care industry, announced today that ... serve the industry in the area of incentive ... seasoned health and productivity professionals have long been ...
... to help health care providers,prepare patients for a colonoscopy ... makes TriLyte(R) (PEG-3350, sodium chloride, sodium bicarbonate,and potassium chloride ... is indicated for bowel cleansing prior to a,colonoscopy. , ... patients who are preparing for a,colonoscopy by explaining the ...
Cached Medicine News:Health News:U.S. Media Report From Uganda: Wilson Center Panel Discusses Health, Environment, and Security in Africa 2Health News:Recently Reported Childhood Deaths from Influenza Are a Stark Reminder to Vaccinate Now 2Health News:GIVE IT A REST: Delta Dental of Illinois Encourages Routine Dental Exams to Help Detect Nighttime Teeth Grinding 2Health News:Next Generation Waters Successfully Reaches Over 300 Stores! 2Health News:IncentOne Launches Consulting Practice 2Health News:Free Video for Health Care Providers and Patients Who are Preparing for a Colonoscopy Is Now Available at www.TriLyte.com 2
(Date:8/29/2014)... , Aug. 29, 2014   Mast Therapeutics, ... company, announced today that Santosh Vetticaden, Chief Medical ... the Company, for personal reasons, in mid-September.  ... Officer of Aires Pharmaceuticals, which Mast acquired earlier ... as the Company,s interim Chief Medical Officer.  Dr. ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Peptide Cancer Therapeutics Market & Pipeline ... The conventional methods developed to prevent and eradicate ... cancer treatment. These methods are confined to low specificity, ... the researchers to look for a better solution. It ...
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2
... RIDGEFIELD, CT, Sept. 21, 2011 Boehringer Ingelheim,s investigational ... trend in reducing lung function decline in patients with ... trial results published today online in the New ... is a progressive and severely debilitating lung disease with ...
... new electronic medication system, the Artemis system, is now in ... which adds a new level of safety when it ... an emergency situation. The Artemis system ...  Dr. James Broselow, inventor of ,The Broselow Tape, and Dr. ...
Cached Medicine Technology:New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 2New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 3New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 4New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis 5New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 2New Electronic Child Medication Safety System Launches at Rocky Mountain Hospital for Children at Presbyterian/St. Luke's Medical Center 3
Double-ended. 5 mm x 7 mm tips. Designated most popular model or size....
Double-ended. 3 mm x 5 mm curette end and 3 mm spatula end....
Double-ended. Semi sharp. Curved 3 mm tips. Angled right and left....
Double-ended. Designated most popular model or size....
Medicine Products: